pirinixic acid has been researched along with Diabetes Mellitus, Lipoatrophic in 1 studies
pirinixic acid: structure
Diabetes Mellitus, Lipoatrophic: A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, CJ | 1 |
| Haluzik, M | 1 |
| Gregory, C | 1 |
| Dietz, KR | 1 |
| Vinson, C | 1 |
| Gavrilova, O | 1 |
| Reitman, ML | 1 |
1 other study available for pirinixic acid and Diabetes Mellitus, Lipoatrophic
| Article | Year |
|---|---|
WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.
Topics: Acetyl-CoA Carboxylase; Animals; Blood Glucose; Diabetes Mellitus, Lipoatrophic; Fatty Acids, Nonest | 2002 |